evekhm/cms_iom_500 huggingface dataset:
Article - Billing and Coding: Advance Care Planning (A58664)
CMS National Coverage PolicyTitle XVIII of the Social Security Act, 1833(e) prohibits Medicare payment for any claim which lacks the necessary information to process the claim.42 CFR 419.22(t) addresses annual wellness visits providing personalized prevention plan services.42 CFR 410.15 Annual wellness visits providing Personalized Prevention Plan Services: Conditions for and limitations on coverage42 CFR 410.16 Initial preventive physical examination: Conditions for and limitations on coverageCMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 15, 280.5.1 Advance Care Planning (ACP) Furnished as an Optional Element with an Annual Wellness Visit (AWV) Upon Agreement with the PatientCMS Internet-Only Manual, Pub. 100-04, Medicare Claims Processing Manual, Chapter 18, 140.8 Advance Care Planning (ACP) as an Optional Element of an Annual Wellness Visit (AWV)Federal Register, Vol. 80, No. 220, dated Monday, November 16, 2015, pages 70955-70959Novitas 2017 Evaluation and Management (E/M) Service: Face-to-Face DocumentationMedicare Learning Network MattersArticle: MM9271/CR9271/R216BP and R3428CPMLN Fact Sheet-Advance Care Planning: ICN MLN909289 October 2020Frequently Asked Questions about Billing the Physician Fee Schedule for Advance Care Planning Services, July 14, 2016Article TextThe information in this article contains billing, coding or other guidelines that complement the Local Coverage Determination (LCD) for Advance Care Planning L38970.Voluntary Advance Care Planning (ACP) is a face-to-face service between a Medicare physician (or other qualified health care professional) and a patient and/or family member(s), and/or surrogate to discuss the patients health care wishes if they become unable to make decisions about their care.A surrogate is defined as a healthcare agent, designated decision maker, family member, or caregiver.If a patient is unable to be present, ACP documentation must reflect the reason why the patient is unable to participate.Qualified providers, defined under Medicare Part B, include physicians (MD/DO), Nurse Practitioners and Physician Assistants, and Clinical Nurse Specialists.
Article - Billing and Coding: Advance Care Planning (A58664)
Qualified providers, defined under Medicare Part B, include physicians (MD/DO), Nurse Practitioners and Physician Assistants, and Clinical Nurse Specialists.Other team members may participate in the provision of ACP under the order and medical management of the beneficiarys treating physician. The CPTcode descriptors describe the services as furnished by physicians or other qualified health professionals, which for Medicare purposes is consistent with allowing these codes to be billed by the physicians and other qualified providers, whose scope of practice and Medicare benefit category include the services described by the CPTcodes and who are authorized to independently bill Medicare for those services. Therefore, only these practitioners may report CPTcodes 99497 and 99498. ACP services are the provenance of patients and physicians. The billing physician or qualified provider must participate and meaningfully contribute to the provision of ACP, in addition to providing a minimum of direct supervision. The usual physician fee schedule (PFS) payment rules regarding incident to services apply.All other providers (social work, psychology, chaplains) may not report ACP codes independently.ACP services can be provided in facility or non-facility settings. ACP codes can be reported when services are provided in any care setting including an office, hospital, skilled nursing facility (SNF), home, and via the specific Centers for Medicare and Medicaid Services (CMS) guidelines for telehealth in effect at the time of service. Place of service (POS) must be included when reporting ACP services.ACP services are not limited to a particular specialty.For patients receiving hospice benefits, ACP services can be billed under Medicare Part B, only if the practitioner is not employed by the hospice agency; otherwise, the ACP services would be billed on the Type of Bill 081x or 082x when performed by hospice employed physicians or by physicians who are under arrangement with the hospice.There is no limit on the number of times that ACP services can be reported for a given patient in a given time period. However, if these services are billed more than once, a change in the patients health status and/or wishes about end-of-life care must be documented. Some people may need ACP multiple times in a year if they are quite ill and/or their circumstances change. Others may not need the service at all in a year.
Article - Billing and Coding: Advance Care Planning (A58664)
Voluntary ACP can be offered upon agreement with the patient, family member or surrogate. That agreement must be documented in the medical record.Medicare pays for ACP as either:An optional element of a Medical Wellness Visit (MWV), which includes the Annual Wellness Visit (AWV); orA separate Medicare Part B medically necessary serviceCPTcodes 99497 and 99498 are time based codes (a base code and an add-on code). Practitioners should consult CPTprovisions regarding minimum time required to report timed services. Use CPTcode 99497 for the first 16 to 30 minutes. Use CPTcode 99498 for each additional 30 minutes. If the required minimum time is not spent with the patient, family member(s) and/or surrogate to bill CPTcodes 99497 or 99498, the practitioner may consider billing a different evaluation and management (E/M) service provided the requirements for billing the other E/M service are met. No other active management of the patients problems should be undertaken for the time period reported when ACP codes are used.When a patient gets ACP services outside of MWV, the patient should be told that the Part B cost sharing (deductible and coinsurance) applies.Medicare waives the ACP coinsurance and the Part B deductible when the ACP is:Delivered on the same day as a covered MWV (HCPCS codes G0438 or G0439)Offered by the same provider as a covered MWVBilled with modifier 33 (Preventive Services)If Medicare denies the MWV for exceeding the once-per-year limit, Medicare can still make the ACP payment as a separate Medicare Part B medically necessary service. In that case, Medicare applies the deductible and coinsurance to the ACP service.Documentation:At a minimum, and as noted above, appropriate documentation must include the content and the medical necessity of the ACP related discussion, the voluntary nature of the encounter, the content of any advance directives (along with completion of advance directive forms, when performed), the names of participants in the discussion; and the time spent in the face-to-face encounter. Best practice for the time documentation is to include the start and end time of the face-to-face conversation.Diagnosis Coding:
Article - Billing and Coding: Advance Care Planning (A58664)
Diagnosis Coding:The condition(s) for which the patient receives counseling in the course of ACP should be coded per the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD 10-CM). When part of an MWV, the code should report an administrative examination or a well exam diagnosis.CPTCoding:Hospitals, physicians or non-physician practitioners (NPP) may bill ACP services, if the practice scope and Medicare benefit category include the services described below.CPTcode 99497: Advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogateCPTcode 99498: Advance care planning including the explanation and discussion of advance directives, such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; each additional 30 minutes (List separately in addition to code for primary procedure)CPTcodes 99497-99498 should not be reported by the same physician/qualified health provider on the same date of service as the following E/M services: 99291-99292, 99468-99469, 99471-99472, 99475-99480 and 99483.
Article - Billing and Coding: Advance Care Planning (A58664)
CPTinstructions note that CPTcodes 99497 and 99498 may be billed on the same day or a different day as most other E/M services, and during the same service period as transitional care management services or chronic care management services and within global surgical periods.These codes may be separately reported when performed on the same date of service in conjunction with the following E/M services: 99201-99215, 99217-99226, 99231-99236, 99238-99239, 99241-99245, 99251-99255, 99281-99285, 99304-99310, 99315-99316, 99318, 99324-99328, 99334-99337, 99341-99345, 99347-99350, 99381-99397, and 99495-99496. Both codes should be reported with modifier-25 added presuming the requirements for use of modifier-25 are met.Note: Critical Access Hospitals (CAHs) may bill ACP services using type of bill 85X with revenue codes 96X, 97X, and 98X. Medicare bases the CAH Method II payment on the lesser of the actual charge or the facility-specific Medicare PFS.ACP provision by Federally Qualified Health Centers and Rural Health Clinics are paid under a special all-inclusive rate or prospective payment system (PPS), in which ACP is part of the bundled services.
Article - MolDX: Algorithm definition as a component of a laboratory test (A58673)
CMS National Coverage PolicyN/AArticle TextThe aim of this article is to promote a shared understanding of the term "algorithm" within the context of a clinical laboratory test. The objective of this article is to communicate the attributes of an algorithm as defined by this contractor within the stated context. The presence or absence of an algorithm as part of a lab service may be relevant to understanding the components of that service for coding or valuation purposes.An algorithm may be considered a meaningful and independent component of a laboratory process when ALL the following conditions are met:It is an unambiguous problem-solving operation that includes deploying a set of rules or calculations requiring computer processing;The test result (or a component of the result) is the calculated output of this process, and not an intermediary process;The same or similar test result could not be obtained without the use of this process;The input for the computation is derived from biological samples using analytical processes, and must include data from the sample submitted for the test;The process must:Either be required for the analytical result, ORIf adjunct to the analytical result as a post-analytical process, the calculation itself must be independently found to be reasonable and necessary apart from the other components of the test.Examples:A gene expression profile test wherein sequencing data must be compared in a calculation to an existing and validated set of profiles to bin it in one of several possible risk stratification groups would require the use of an algorithm as defined above.A next generation sequencing (NGS) test that uses computation to identify variants in a sampleis notconsidered as using an algorithm in this context. The calculation in this scenario is seen as an intermediary process.Calculations using only clinical information not derived from analytical services on biological samplesare notconsidered algorithms in this context. Examples would include using the clinical information from the patient in a calculation to assess their risk stratification or using a similar process to identify relevant clinical annotations derived from literature as associations with sequencing variants.A test that inputs resultant analytical processes that are reasonable and necessary (such as gene variants or protein markers) that are post processed by computation, but wherein that subsequent computation is not independently established as reasonable and necessary above and beyond the other lab components, shall not be considered an algorithm as a valid component of a laboratory test.
Article - MolDX: Algorithm definition as a component of a laboratory test (A58674)
CMS National Coverage PolicyN/AArticle TextThe aim of this article is to promote a shared understanding of the term "algorithm" within the context of a clinical laboratory test. The objective of this article is to communicate the attributes of an algorithm as defined by this contractor within the stated context. The presence or absence of an algorithm as part of a lab service may be relevant to understanding the components of that service for coding or valuation purposes.An algorithm may be considered a meaningful and independent component of a laboratory process when ALL the following conditions are met:It is an unambiguous problem-solving operation that includes deploying a set of rules or calculations requiring computer processing;The test result (or a component of the result) is the calculated output of this process, and not an intermediary process;The same or similar test result could not be obtained without the use of this process;The input for the computation is derived from biological samples using analytical processes, and must include data from the sample submitted for the test;The process must:Either be required for the analytical result, ORIf adjunct to the analytical result as a post-analytical process, the calculation itself must be independently found to be reasonable and necessary apart from the other components of the test.Examples:A gene expression profile test wherein sequencing data must be compared in a calculation to an existing and validated set of profiles to bin it in one of several possible risk stratification groups would require the use of an algorithm as defined above.A next generation sequencing (NGS) test that uses computation to identify variants in a sampleis notconsidered as using an algorithm in this context. The calculation in this scenario is seen as an intermediary process.Calculations using only clinical information not derived from analytical services on biological samplesare notconsidered algorithms in this context. Examples would include using the clinical information from the patient in a calculation to assess their risk stratification or using a similar process to identify relevant clinical annotations derived from literature as associations with sequencing variants.A test that inputs resultant analytical processes that are reasonable and necessary (such as gene variants or protein markers) that are post processed by computation, but wherein that subsequent computation is not independently established as reasonable and necessary above and beyond the other lab components, shall not be considered an algorithm as a valid component of a laboratory test.
Article - MolDX: Algorithm definition as a component of a laboratory test (A58677)
CMS National Coverage PolicyN/AArticle TextAn algorithm may be considered a meaningful and independent component of a laboratory process when ALL the following conditions are met:It is an unambiguous problem-solving operation that includes deploying a set of rules or calculations requiring computer processing;The test result (or a component of the result) is the calculated output of this process, and not an intermediary process;The same or similar test result could not be obtained without the use of this process;The input for the computation is derived from biological samples using analytical processes, and must include data from the sample submitted for the test;The process must:Either be required for the analytical result, ORIf adjunct to the analytical result as a post-analytical process, the calculation itself must be independently found to be reasonable and necessary apart from the other components of the test.Examples:A gene expression profile test wherein sequencing data must be compared in a calculation to an existing and validated set of profiles to bin it in one of several possible risk stratification groups would require the use of an algorithm as defined above.A next generation sequencing (NGS) test that uses computation to identify variants in a sampleis notconsidered as using an algorithm in this context. The calculation in this scenario is seen as an intermediary process.Calculations using only clinical information not derived from analytical services on biological samplesare notconsidered algorithms in this context. Examples would include using the clinical information from the patient in a calculation to assess their risk stratification or using a similar process to identify relevant clinical annotations derived from literature as associations with sequencing variants.A test that inputs resultant analytical processes that are reasonable and necessary (such as gene variants or protein markers) that are post processed by computation, but wherein that subsequent computation is not independently established as reasonable and necessary above and beyond the other lab components, shall not be considered an algorithm as a valid component of a laboratory test.
Article - Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58679)
CMS National Coverage PolicyTitle XVIII of the Social Security Act, 1833(e) prohibits Medicare payment for any claim which lacks the necessary information to process the claim.CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 15, 80.1.2 A/B MAC (B) Contacts With Independent Clinical LaboratoriesCMS Internet-Only Manual, Pub. 100-04, Medicare Claims Processing Manual, Chapter 16, 50.5 Jurisdiction of Laboratory Claims, 60.1.2 Independent Laboratory Specimen Drawing, 60.2. Travel AllowanceCMS Internet-Only Manual, Pub. 100-04, Medicare Claims Processing Manual, Chapter 23, 10 Reporting ICD Diagnosis and Procedure CodesArticle TextThe information in this article contains billing, coding or other guidelines that complement the Local Coverage Determination (LCD) for MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer L38972To report a service, please submit the following claim information:Select appropriate CPTcodeEnter 1 unit of service (UOS)Enter the appropriate DEX Z-Code identifier adjacent to the CPTcode in the comment/narrative field for the following Part B claim field/types:Loop 2400 or SV101-7 for the 5010A1 837PItem 19 for paper claimEnter the appropriate DEX Z-Code identifier adjacent to the CPTcode in the comment/narrative field for the following Part A claim field/types:Line SV202-7 for 837I electronic claimBlock 80 for the UB04 claim formSelect the appropriate ICD-10-CM codeRegarding single-gene and panel testing of genes-Refer to Billing and Coding: MolDX: Testing of Multiple Genes A58120.Tier 1 and/or Tier 2 individual biomarker CPTcodes should not be used for a single gene or any combination of genes when testing is performed as part of a NGS or other multiplexing technology panel.
Article - Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58681)
CMS National Coverage PolicyTitle XVIII of the Social Security Act, 1833(e) prohibits Medicare payment for any claim which lacks the necessary information to process the claim.CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 15, 80.1.2 A/B MAC (B) Contacts With Independent Clinical LaboratoriesCMS Internet-Only Manual, Pub. 100-04, Medicare Claims Processing Manual, Chapter 16, 50.5 Jurisdiction of Laboratory Claims, 60.1.2 Independent Laboratory Specimen Drawing, 60.2. Travel AllowanceCMS Internet-Only Manual, Pub. 100-04, Medicare Claims Processing Manual, Chapter 23, 10 Reporting ICD Diagnosis and Procedure CodesArticle TextThe information in this article contains billing, coding or other guidelines that complement the Local Coverage Determination (LCD) forMolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with CancerL38974.To report a service, please submit the following claim information:Select appropriate CPTcodeEnter 1 unit of service (UOS)Enter the appropriate DEX Z-Code identifier adjacent to the CPTcode in the comment/narrative field for the following Part B claim field/types:Loop 2400 or SV101-7 for the 5010A1 837PItem 19 for paper claimEnter the appropriate DEX Z-Code identifier adjacent to the CPTcode in the comment/narrative field for the following Part A claim field/types:Line SV202-7 for 837I electronic claimBlock 80 for the UB04 claim formSelect the appropriate ICD-10-CM codeRegarding single-gene and panel testing of genes-Refer to Billing and Coding: MolDX: Testing of Multiple Genes A58121.Tier 1 and/or Tier 2 individual biomarker CPTcodes should not be used for a single gene or any combination of genes when testing is performed as part of a NGS or other multiplexing technology panel.
Article - MolDX: Algorithm definition as a component of a laboratory test (A58689)
CMS National Coverage PolicyN/AArticle TextThe aim of this article is to promote a shared understanding of the term "algorithm" within the context of a clinical laboratory test. The objective of this article is to communicate the attributes of an algorithm as defined by this contractor within the stated context. The presence or absence of an algorithm as part of a lab service may be relevant to understanding the components of that service for coding or valuation purposes.An algorithm may be considered a meaningful and independent component of a laboratory process when ALL the following conditions are met:It is an unambiguous problem-solving operation that includes deploying a set of rules or calculations requiring computer processing;The test result (or a component of the result) is the calculated output of this process, and not an intermediary process;The same or similar test result could not be obtained without the use of this process;The input for the computation is derived from biological samples using analytical processes, and must include data from the sample submitted for the test;The process must:Either be required for the analytical result, ORIf adjunct to the analytical result as a post-analytical process, the calculation itself must be independently found to be reasonable and necessary apart from the other components of the test.Examples:A gene expression profile test wherein sequencing data must be compared in a calculation to an existing and validated set of profiles to bin it in one of several possible risk stratification groups would require the use of an algorithm as defined above.A next generation sequencing (NGS) test that uses computation to identify variants in a sampleis notconsidered as using an algorithm in this context. The calculation in this scenario is seen as an intermediary process.Calculations using only clinical information not derived from analytical services on biological samplesare notconsidered algorithms in this context. Examples would include using the clinical information from the patient in a calculation to assess their risk stratification or using a similar process to identify relevant clinical annotations derived from literature as associations with sequencing variants.A test that inputs resultant analytical processes that are reasonable and necessary (such as gene variants or protein markers) that are post processed by computation, but wherein that subsequent computation is not independently established as reasonable and necessary above and beyond the other lab components, shall not be considered an algorithm as a valid component of a laboratory test.